🎉 M&A multiples are live!
Check it out!

Public Comps and Valuation Multiples
for Biopharmaceuticals

Benchmark revenue and EBITDA valuation multiples for public comps like Eli Lilly, Johnson & Johnson, Amgen, Pfizer and Novartis.

Biopharmaceuticals

See analyst estimates and all valuation multiples for Biopharmaceuticals
Company EV EV/LTM Revenue EV/LTM EBITDA
$990B 16.1x 36.2x
$524B 5.6x 14.8x
$469B 7.8x 18.3x
$333B 4.4x 11.1x
$307B 5.3x 15.2x
$272B 4.2x 9.4x
$267B 4.8x 11.7x
$225B 6.2x 12.4x
$207B n/a n/a
$189B 3.0x 7.6x
$173B 5.9x 11.2x
$132B 2.8x 7.6x
$128B n/a n/a
$113B 2.7x 7.9x
$103B 8.7x 20.8x
$82.2B 10.4x 20.5x
$72.1B 1.4x 6.5x
$69.6B 2.4x 9.0x
$67.0B 2.7x 9.6x
$66.4B 4.2x 12.6x
$59.3B 6.3x 14.4x
$51.1B n/a n/a
$51.1B 11.1x 36.9x
$51.0B 5.5x 18.8x
$45.0B n/a n/a
$43.5B n/a n/a
$41.2B n/a n/a
$33.9B n/a n/a
$29.1B n/a n/a
$28.6B n/a n/a
$27.0B n/a n/a
$26.9B 13.3x 35.6x
$25.7B 1.8x 6.2x
$25.3B 2.0x 8.8x
$24.1B 8.1x 8.4x
$22.0B 62.0x 23879.5x
$22.0B n/a n/a
$19.3B 10.7x 80.6x
$18.9B 130.6x 249.3x
$16.7B 1.9x 8.0x
$15.8B n/a n/a
$14.7B 3.2x 11.8x
$14.2B 10.2x 31.1x
$14.1B 4.7x 12.7x
$13.5B 4.6x 11.9x
$13.4B 4.8x 20.2x
$13.0B 28.6x -919.8x
$12.9B 46.8x -275.3x
$12.9B 2.2x 12.6x
$12.4B 3.9x 16.0x
$12.2B 2.1x 14.3x
$11.7B 0.3x 5.2x
$11.4B 2.7x 7.1x
$11.2B 3.0x 12.1x
$11.1B 3.6x 9.0x
$10.8B n/a n/a
$10.6B 3.8x 13.7x
$10.5B n/a n/a
$10.4B 12.8x 40.6x
$10.1B 3.7x 14.4x
$10.1B 3.1x 7.4x
$10.0B 1.6x 5.2x
$9.9B 1.6x 12.6x
$9.8B n/a n/a
$9.8B 2.5x 9.9x
$9.7B n/a n/a
$9.5B 7.3x 11.1x
$8.8B 3.6x 5.6x
$8.0B 1.6x 12.6x
$7.9B n/a n/a
$7.8B n/a n/a
$7.6B 2.1x 10.1x
$7.2B 4.6x 23.2x
$7.1B 2.3x 10.2x
$7.0B 3.7x 18.1x
$6.8B n/a n/a
$6.7B 17.6x -423.3x
$6.5B 2.8x 10.3x
$6.3B 5.5x 18.6x
$6.3B 2.1x 9.3x
$6.3B 1.5x 8.3x
$6.0B 1.8x 7.1x
$5.9B 1.9x 7.8x
$5.8B 3.9x 45.9x
$5.8B 15.6x 23.4x
$5.7B n/a -21.5x
$5.7B 84.9x -690.1x
$5.6B 3.4x 18.5x
$5.5B n/a n/a
$5.4B 2.8x 11.0x
$5.1B n/a n/a
$5.1B 6.0x 27.3x
$4.9B n/a n/a
$4.9B 1.8x 4.8x
$4.8B 8.3x 24.6x
$4.7B n/a n/a
$4.7B 4.9x 13.1x
$4.6B n/a n/a
$4.5B n/a -28.3x
$4.5B 4044.7x -15.7x
$4.5B 5.4x 18.8x
$4.4B n/a n/a
$4.4B 8.8x 23.0x
$4.4B n/a n/a
$4.3B n/a n/a
$4.1B n/a n/a
$4.0B n/a -10.4x
$4.0B 3.9x 17.9x
$3.8B n/a n/a
$3.8B 129.8x n/a
$3.7B 10.8x -257.5x
$3.7B 2.2x 10.9x
$3.6B n/a n/a
$3.5B n/a n/a
$3.5B n/a n/a
$3.4B 5.0x 16.3x
$3.3B n/a n/a
$3.3B 6.9x -259.0x
$3.2B 7.6x -46.0x
$3.1B n/a n/a
$3.1B 2.4x 11.6x
$3.0B n/a n/a
$3.0B n/a -13.1x
$3.0B n/a n/a
$3.0B 1.4x 9.5x
$2.9B n/a n/a
$2.9B n/a n/a
$2.8B 4.4x 30.8x
$2.8B n/a -14.5x
$2.8B 6.9x 20.7x
$2.7B 4.3x 10.2x
$2.6B 13.6x 23.1x
$2.6B 4.1x 13.8x
$2.5B n/a n/a
$2.5B 20.3x -130.0x
$2.3B 3.4x 17.8x
$2.3B 2.8x 13.5x
$2.2B n/a -20.1x
$2.2B 3.6x 14.2x
$2.2B 2.8x 18.1x
$2.2B 2.6x 9.9x
$2.2B 11.8x 34.9x
$2.2B 8.2x 75.0x
$2.1B 8.9x -5.7x
$2.1B 5.7x 16.5x
$2.1B n/a n/a
$2.1B 6.8x 17.6x
$2.1B 13.8x n/a
$2.0B 40.9x n/a
$2.0B 5.2x 14.4x
$2.0B 2.6x 4.4x
$1.9B n/a -9.1x
$1.9B 8.4x -70.1x
$1.9B n/a n/a
$1.8B 48.3x -8.9x
$1.7B n/a n/a
$1.7B 3.9x n/a
$1.7B 3.9x 14.4x
$1.7B n/a n/a
$1.6B n/a -9.9x
$1.6B n/a n/a
$1.6B 2.5x 11.5x
$1.6B 6.0x 23.9x
$1.6B 8.4x 27.1x
$1.6B 2.2x 6.1x
$1.6B n/a n/a
$1.6B 0.7x 4.2x
$1.5B n/a n/a
$1.5B n/a n/a
$1.5B n/a n/a
$1.5B n/a n/a
$1.5B n/a n/a
$1.4B 6.3x 25.9x
$1.4B n/a n/a
$1.4B 14.3x n/a
$1.4B n/a n/a
$1.3B 4.8x 27.9x
$1.3B 24.4x 56.4x
$1.3B n/a n/a
$1.3B 4.6x 9.1x
$1.3B n/a n/a
$1.3B 21.0x n/a
$1.3B 0.6x 6.3x
$1.3B n/a n/a
$1.3B 8.2x -4.7x
$1.3B 11.4x -11.0x
$1.3B n/a n/a
$1.2B n/a n/a
$1.2B 37.6x -11.4x
$1.2B n/a n/a
$1.2B 2.0x -194.9x
$1.1B n/a n/a
$1.1B n/a n/a
$1.1B n/a n/a
$1.1B n/a n/a
$1.1B n/a n/a
$1.0B 398.0x -7.1x
$1.0B n/a n/a
$1.0B n/a -9.7x
$1.0B n/a n/a
$999M 3.3x 7.3x
$989M n/a -6.4x
$988M n/a n/a
$985M 1.2x 4.9x
$979M 3.0x 36.0x
$978M 1.6x -7.0x
$969M n/a n/a
$967M 2.5x 33.1x
$967M n/a n/a
$937M n/a n/a
$920M n/a -7.2x
$873M n/a n/a
$864M n/a -6.0x
$855M n/a n/a
$853M 68.0x -2.6x
$849M n/a n/a
$826M 25.0x -12.8x
$814M 108397.6x -7.2x
$799M n/a n/a
$794M 6.2x -4.8x
$784M n/a n/a
$779M 1.3x 6.4x
$750M 1.7x 8.1x
$746M n/a -5.2x
$728M 55.1x n/a
$727M n/a n/a
$713M n/a n/a
$691M 2.5x 11.6x
$677M 6.4x 23.7x
$666M 77.0x -5.3x
$645M 14.6x 118.7x
$620M n/a n/a
$588M n/a -4.0x
$577M n/a -3.9x
$577M 90.3x -3.7x
$563M 3.6x 20.9x
$549M n/a n/a
$536M 27.6x -171.6x
$515M n/a n/a
$510M n/a -2.4x
$507M 175.2x -25.9x
$503M 20398.2x n/a
$496M 37.6x 73.9x
$488M 5.0x 13.9x
$463M 3.2x -3.5x
$461M n/a n/a
$456M 10.0x -6.1x
$456M 33.6x -10.3x
$451M 7.0x -21.1x
$440M n/a n/a
$440M n/a n/a
$432M n/a n/a
$421M 2.2x -3.6x
$421M 2.3x 9.6x
$421M n/a n/a
$416M 1.4x 9.5x
$412M 77.9x -12.8x
$395M 6.3x 24.8x
$386M 1.2x 4.4x
$372M 19.2x -1295.0x
$371M 15.6x -7.5x
$356M 1.2x 9.8x
$341M 2.8x 54.7x
$339M 11.2x -1.7x
$335M 30462.2x -3.7x
$335M n/a n/a
$331M n/a n/a
$312M n/a n/a
$311M 1.3x n/a
$310M 0.8x 9.4x
$305M n/a n/a
$291M 4.2x 22.8x
$262M n/a n/a
$256M 6.4x -30.3x
$255M n/a n/a
$254M 2.5x 7.7x
$254M n/a n/a
$238M n/a n/a
$238M 10.3x n/a
$237M 12.7x 213.2x
$235M n/a n/a
$231M 1.7x 16.2x
$226M 2.7x -10.1x
$220M n/a -15.8x
$218M n/a -29.2x
$217M 3.4x 7.5x
$216M n/a n/a
$211M 25.5x -7.0x
$211M 10.6x -5.0x
$205M n/a n/a
$201M 4.7x 22.9x
$191M n/a n/a
$188M 2.9x n/a
$181M n/a n/a
$178M 6.1x n/a
$170M 132.8x -4.5x
$169M 46.4x -3.8x
$167M 30.2x -12.6x
$162M 4.8x n/a
$153M n/a n/a
$145M n/a n/a
$140M 17.0x -6.2x
$138M 2.5x 118.1x
$136M n/a n/a
$136M 5.9x -3.7x
$130M n/a n/a
$128M n/a n/a
$126M 27.9x -1.9x
$125M 9.2x -3.1x
$125M n/a n/a
$124M 21.6x -10.3x
$122M n/a n/a
$120M 2.0x n/a
$112M 89.6x -22.2x
$112M n/a n/a
$111M n/a -8.4x
$108M n/a n/a
$104M n/a n/a
$102M 1.5x 9.1x
$100M n/a n/a
$97.9M 6.6x 22.7x
$91.7M n/a n/a
$90.5M 28.8x -1.6x
$89.3M 18.9x -0.6x
$84.9M n/a n/a
$84.1M n/a n/a
$83.6M n/a n/a
$80.8M n/a -1.6x
$79.5M n/a n/a
$78.7M n/a n/a
$77.8M n/a n/a
$76.9M n/a n/a
$75.1M n/a n/a
$74.3M n/a n/a
$73.4M n/a n/a
$65.5M n/a n/a
$64.4M 7.4x -8.5x
$62.5M n/a n/a
$59.4M 556.0x -9.6x
$55.5M n/a n/a
$53.8M n/a n/a
$53.7M n/a n/a
$52.4M n/a n/a
$52.1M 5.5x 2.6x
$50.3M 0.2x -1.0x
$49.1M n/a n/a
$48.0M 35.6x -58.2x
$44.1M n/a n/a
$43.5M 9.1x n/a
$42.2M n/a -2.3x
$41.5M 5.9x n/a
$41.3M 1.6x 11.6x
$39.8M 10.4x n/a
$38.7M 56.9x -4.0x
$35.4M n/a -7.7x
$34.0M n/a n/a
$33.2M n/a n/a
$31.4M 1.7x 39.4x
$30.6M 8.0x n/a
$30.0M n/a n/a
$29.6M n/a n/a
$29.1M n/a n/a
$28.8M n/a n/a
$28.6M 9.1x -6.8x
$28.4M 0.4x -0.1x
$28.4M n/a n/a
$27.9M n/a n/a
$27.8M 29.4x n/a
$27.2M 3.7x -1.4x
$26.7M n/a n/a
$26.7M n/a n/a
$26.6M n/a n/a
$25.7M n/a n/a
$25.5M 0.3x -0.4x
$23.7M 38.3x -2.3x
$23.7M n/a n/a
$23.5M 11.3x 100.2x
$22.8M n/a -12.8x
$20.0M n/a n/a
$20.0M n/a n/a
$19.4M n/a n/a
$19.3M n/a n/a
$19.2M 18.5x -5.2x
$19.0M n/a n/a
$18.9M 2.8x 7.9x
$18.4M n/a n/a
$18.2M n/a -4.4x
$18.0M n/a n/a
$17.8M 13.9x -6.6x
$17.5M n/a -4.2x
$17.3M n/a n/a
$17.0M 7.4x -2.2x
$16.0M n/a n/a
$15.3M n/a n/a
$15.1M n/a -5.3x
$14.5M n/a n/a
$14.3M 2.7x -5.2x
$13.3M 1.8x -8.5x
$13.3M n/a n/a
$13.1M n/a n/a
$13.1M n/a n/a
$12.2M n/a n/a
$12.2M n/a n/a
$11.7M n/a n/a
$11.7M n/a n/a
$11.6M n/a n/a
$11.3M 153.9x -5.4x
$11.1M 11.9x -18.9x
$10.8M n/a n/a
$9.9M n/a -5.0x
$9.9M n/a n/a
$9.8M 7.2x -24.3x
$9.6M 3.0x -3.6x
$9.4M 1.6x -1.0x
$9.3M n/a n/a
$9.1M n/a n/a
$9.0M n/a n/a
$8.7M n/a n/a
$8.6M n/a -2.5x
$8.3M n/a n/a
$8.0M n/a -2.1x
$7.1M n/a n/a
$7.0M n/a -1.3x
$6.9M 13.9x n/a
$6.8M n/a -7.5x
$6.8M n/a n/a
$6.1M n/a n/a
$6.1M n/a n/a
$6.1M n/a n/a
$5.9M 3.3x -0.4x
$5.2M 6.5x -0.4x
$4.7M 3.7x -1.3x
$4.7M n/a n/a
$4.0M n/a -2.4x
$3.9M n/a n/a
$3.7M 32.4x -1.3x
$3.7M n/a n/a
$3.6M 31.2x -1.1x
$3.4M n/a n/a
$3.3M n/a n/a
$3.2M n/a n/a
$3.1M n/a n/a
$3.0M n/a n/a
$2.7M n/a n/a
$2.7M n/a n/a
$2.3M n/a n/a
$2.1M n/a n/a
$1.7M n/a n/a
$1.6M n/a n/a
$1.6M 2.0x -0.1x
$1.3M n/a n/a
$1.2M n/a n/a
$1.2M n/a 0.2x
$1.1M n/a n/a
$0.5M n/a n/a
$0.4M n/a n/a
$0.3M n/a n/a
$0.2M n/a n/a
$0.1M n/a n/a
-$0.1M -0.2x 0.0x
-$0.2M n/a n/a
-$0.3M n/a n/a
-$0.4M n/a n/a
-$0.7M n/a n/a
-$1.4M -0.3x 0.1x
-$4.6M n/a 0.4x
-$6.0M n/a n/a
-$6.4M n/a n/a
-$34.1M n/a n/a
-$85.5M n/a n/a
-$115M n/a n/a
-$1.5B n/a n/a

Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.

See analyst estimates and M&A multiples for Biopharmaceuticals

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.